Recent guidline for hemorrhoids management
Reading File
Finding Sources
Searching PubMed
"hemorrhoids" AND "management" AND "guidelines"
Searching the Web
hemorrhoids management guidelines 2024 2025
Reading File
Reading File
Reading Web Page
ASCRS 2024 hemorrhoids guidelines management classification treatment
Searching PubMed
"hemorrhoids" AND "ASCRS" AND "clinical practice guidelines"
Reading File
Searching PubMed
"Hawkins" AND "hemorrhoids" AND "clinical practice guidelines" AND "colon rectal"
Reading File
I now have comprehensive information to give a thorough, well-structured answer. Here is the consolidated guide based on authoritative textbook content (Sleisenger & Fordtran's GI & Liver Disease), the 2024 ASCRS Clinical Practice Guidelines (Hawkins AT et al., Dis Colon Rectum 2024;67(5):614–623), and recent PubMed evidence.
Hemorrhoids: Current Management Guidelines
Classification
| Grade | Description |
|---|---|
| I | Bleed ± enlarged; no prolapse |
| II | Prolapse with defecation; spontaneous reduction |
| III | Prolapse; requires manual reduction |
| IV | Irreducibly prolapsed |
External hemorrhoids lie distal to the dentate line (squamous epithelium); internal hemorrhoids originate above the dentate line (columnar/transitional mucosa). Pain without thrombosis is unusual — pain should prompt search for another etiology (fissure, abscess).
Step 1 — Conservative (Medical) Management
Indicated for all grades as initial therapy; primary for Grade I–II
Dietary & Lifestyle
- Dietary fiber: 20–30 g/day (gradual increase to avoid gas)
- Fluid intake: 6–8 glasses of non-alcoholic, non-caffeinated fluid daily
- Bowel habit modification: avoid straining, limit time on toilet
- Stool softeners: docusate sodium if stools remain hard
- Osmotic laxatives: polyethylene glycol 3350 for persistent constipation when fiber alone is insufficient
The 2024 ASCRS guidelines define conservative treatment as purely dietary/lifestyle and pharmacological measures — office-based procedures (RBL, sclerotherapy, IRC) are explicitly excluded from this category.
Topical Agents
- Phenylephrine/mineral oil/petrolatum creams — temporary pain/itch relief
- Topical corticosteroids (e.g., hydrocortisone) — short-term use only; risk of candidiasis with prolonged use
- Witch hazel pads, topical anesthetics (benzocaine, pramoxine, dibucaine) — symptomatic relief
- Glycerin suppositories — no proven benefit
Phlebotonics (Venoactive Drugs)
A key 2024 ASCRS update — phlebotonics (flavonoids, micronized purified flavonoid fraction, diosmin/hesperidin) are now formally recognized:
- Improve venous tone, stabilize capillary permeability
- Superior to placebo for bleeding and acute symptoms
- Excellent safety profile
- Particularly useful for Grade II–III hemorrhoids failing fiber therapy
- Largely underutilized in U.S. practice despite strong evidence
Step 2 — Office-Based (Non-Excisional) Procedures
For Grade I–III persisting after conservative management
Rubber Band Ligation (RBL)
- Most common office procedure; preferred for Grade II–III
- Success rate: 65–75%
- Creates fibrosis fixing mucosa to internal sphincter; small amount of tissue removed on sloughing
- Bands placed above the dentate line (squamous mucosa entrapped → immediate pain → remove band)
- 1–3 sessions typically; reassess at 4–6 weeks
- Rare but serious: pelvic sepsis (<1%), delayed hemorrhage (~1%) on day 7–10
- Contraindicated in coagulopathy, immunocompromise (relative), portal hypertension
Sclerotherapy (Injection)
- Grades I–IV (favored in HIV/AIDS — effective even in Grade III–IV)
- Success rate: ~75%
- Agents: sodium tetradecyl sulfate, phenol in oil, polidocanol foam (emerging — 2025 systematic review supports use)
- Rare life-threatening sepsis
Infrared Coagulation (IRC)
- Best for Grade I–II
- Less effective than RBL; rare complications
- Equipment-intensive
Doppler-Guided Hemorrhoidal Artery Ligation (HAL/HAL-RAR)
- Interrupts blood supply via Doppler-guided suture ligation
- Recurrence: ~9% for prolapse, ~7.8% for bleeding at 1 year
- 2024 meta-analysis: blind HAL comparable to Doppler-guided HAL, suggesting efficacy relates to extent of ligation rather than Doppler guidance
- Mucopexy (RAR component) added for prolapse control
Step 3 — Surgical (Excisional) Procedures
For Grade III–IV, failed office procedures, significant external component, or patient preference
Excisional Hemorrhoidectomy
- Gold standard for advanced disease
- Success rate: >85% at 10-year follow-up
- Techniques: Milligan-Morgan (open), Ferguson (closed), LigaSure/energy device
- Most effective and definitive treatment
- Significant postoperative pain is the main drawback
- Botulinum toxin injection: 2025 updated meta-analysis (PMID 40192825) confirms it reduces post-hemorrhoidectomy pain — an emerging adjunct
Procedure for Prolapsing Hemorrhoids (PPH / Stapled Hemorrhoidopexy)
- Grades III–IV
- Success rate: >75%; randomized trials show higher long-term recurrence vs. excisional hemorrhoidectomy
- Significantly less postoperative pain overall, but subset experience severe persistent pain or defecation urgency
- Rare but serious: pelvic sepsis, rectal perforation, death reported
Laser Hemorrhoidoplasty (LHP)
- Emerging minimally invasive technique
- 2024 practice guideline (PMID 39579281) and 2024 systematic review (PMID 39048788, 980 nm vs. 1470 nm wavelengths) support use for symptomatic hemorrhoids
- Less pain, faster recovery; long-term data still accumulating
Treatment Selection Summary
Grade I: Conservative → IRC or RBL (proximal banding) if bleeding persists
Grade II: Conservative → RBL (first-line procedural) → Hemorrhoidectomy if failed
Grade III: Conservative → RBL or HAL-RAR → Hemorrhoidectomy
Grade IV: Conservative (acute management) → Hemorrhoidectomy (definitive)
Thrombosed external: Excision within 72 h of onset (most effective); sitz baths if >72 h
Special Populations
| Population | Key Points |
|---|---|
| Pregnancy | Conservative first (sitz baths, stool softeners, fiber); RBL for refractory cases; hemorrhoidectomy if severe prolapse/ulceration/bleeding |
| Anticoagulated patients | Avoid RBL if possible; IRC safer; coordinate anticoagulation management |
| Portal hypertension | Avoid RBL (risk of massive hemorrhage); conservative/sclerotherapy preferred |
| Immunocompromised/HIV | Sclerotherapy preferred over RBL; avoid if neutropenic; bowel prep recommended |
| IBD | Extreme caution with procedural/surgical therapy; conservative preferred |
Key Takeaways from 2024 ASCRS Guidelines
- Fiber and fluid modification remain the foundation for all grades
- Phlebotonics now have formal recommendation — consider in Grade II–III before escalating to procedures
- Conservative treatment = dietary/pharmacological only (RBL/IRC are "office procedures," not "conservative")
- RBL remains the preferred office procedure for Grade II–III
- Hemorrhoidectomy remains gold standard for advanced/refractory disease
- Laser techniques and HAL are acceptable alternatives with growing evidence
Sources:
- Sleisenger & Fordtran's Gastrointestinal and Liver Disease, 11e — Chapter 129
- Hawkins AT et al. ASCRS Clinical Practice Guidelines for Hemorrhoids. Dis Colon Rectum 2024;67(5):614–623
- LHP Recommendation Development Group. Tech Coloproctol 2024 [PMID 39579281]
- Quinn R et al. Botulinum toxin for post-hemorrhoidectomy pain. Tech Coloproctol 2025 [PMID 40192825]
- Liew AN et al. HAL blind vs Doppler — systematic review. ANZ J Surg 2024 [PMID 39465535]
This is a shared conversation. Sign in to Orris to start your own chat.